IMCR buy at $4.IMCR is a stock that had a lot of big name investors but it could be ready for a deep dive down to $4 as describe on the chart.
Not a financial advise.
IMCR trade ideas
$IMCR Pullback Buy SetupI bought this NASDAQ:IMCR pullback buy setup on July 5th and got stopped out for 5% gain.
It is potentially setting put another pullback buy setup.
Previous entry and exit on chart marked as dashes.
IMCR Short [Trend Reversal]Market Phase & Period:
Uptrend. February 2022 - November 2022
Description:
The trend reached its highs in November 2022 but failed to continue in February 2023, making a double top pattern.
The selling pressure observed in February-March 2023 indicates weakness in the bullish momentum, with the price easily reaching $47.
April showed some positive movement for the bulls, where the price reached $62 and remained around that level.
There has been a decrease in volume since November 2022, indicating a reduced interest in the stock.
Action:
Considering a short trade with a target at $40 and a stop above the level. The RR ratio is not great, but decent.
Risks:
One risky aspect is the low volume on the day of the trade, but let's see how it plays out.
P.S. When I refer to the "price," I mean the area near the price. It's important to note that the price always needs some space to move.
Young biotech leader $IMCR with good VCPImmunocore Holdings is a commercial-stage T cell receptor biotechnology company working to develop and commercialize transformative medicines for oncology, infectious diseases and autoimmune and inflammation diseases.
In a confirmed uptrend, yesterday signaled a good pivot buy where I placed an initial position.
I liked the volatility contraction pattern and the bullish divergence with the 10-day ROC prior to the breakout, and now I'll wait for the follow through action to add to the position.
Lets wait and see.
Big sell off on trial results. Oversold perhaps?Investors reacted strongly to the downside on news of the latest trial results, while the companies headline read more bullish.
Going to look at this one as potentially oversold - time will tell of course.
Could look at a stop limit buy order where if the stock recovers then you can enter the trade, but if it continues to head down then you stay out. Would also suggest of course a stop loss as well.
Might be one for the watch list to do more research around if you like this kind of potentially oversold on news type play.
Buyer beware :)
$IMCR Box SetupA recent Biotech IPO that could be putting in the bottom of its IPO base. Breaking its downtrend (red line) and volatility contracting and forming a tight box setup. On focus list for next week.
Immunocore Hldgs Plc Ads (IMCR)- DEVELOPS AND MARKETS IMMUNOTHERAPIES WITH T-CELL RECEPTORS TO TREAT CANCER, INFECTIOUS AND AUTOIMMUNE.
$IMCR is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Immunocore is a developer of a novel class of TCR (T cell receptor) bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, infectious and autoimmune.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $42,41;
stop-loss — $35,71;
take-profit — 61,69/MOC price.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
